pharma · Menopause · Vulvovaginal Atrophy · TXMD
TherapeuticsMD
TherapeuticsMD is a pharma organization headquartered in Boca Raton, USA. It trades on NYSE under ticker TXMD. Primary therapeutic focus areas include Menopause, Vulvovaginal Atrophy, Secondary Amenorrhea, Contraception,
Boca Raton, USA HQ
53 Employees
Public company Type
TXMD · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boca Raton, USA
- Employees
- 53
- Programs
- 6
- Drugs
- 6
- Patents
- 0
Estradiol
Phase 3 · small molecule · Vulvovaginal Atrophy
Estradiol for Vulvovaginal Atrophy is a Phase 3 program (small_molecule) at TherapeuticsMD with 1 ClinicalTrials.gov record(s).
Internal code TXV14-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- TherapeuticsMD
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Vulvovaginal Atrophy
- Status
- completed
- Trials
- 1